array biopharma inc
(ARRY:Consolidated Issue listed on NASDAQ Global Market)
Randall K. Johnson Ph.D.
Member of Scientific Advisory Board, Array BioPharma, Inc.
|Age||Total Calculated Compensation||This person is connected to 96 board members in 9 different organizations across 13 different industries.|
See Board Relationships
Dr. Randall K. Johnson, Ph.D. served as Director of the Department of Biomolecular Discovery, Development Project Leader, Associate Director at the Departments of Natural Products Pharmacology and Molecular Pharmacology, Research Program Leader and Group Director of the Department of Oncology Research of SmithKline Beecham and GlaxoSmithKline. Dr. Johnson has over 35 years of experience in the discovery and development of anti-cancer agents. Dr. Johnson's experience ...
3200 Walnut StreetPhone: 303-381-6600
Boulder, Colorado 80301
Board Members Memberships*
Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Special Project Committee
University of Minnesota
George Washington University
Institut National Du Cancer
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Harvey J. Berger M.D.||Principal Founder, Chairman of the Board, Chief Executive Officer, President and Chairman of Executive Committee|
Ariad Pharmaceuticals Inc.
|Daniel R. Passeri MSc., J.D.||Chief Executive Officer and Director|
|Michael M. Morrissey Ph.D.||Chief Executive Officer, President and Director|
|Werner Lanthaler MBA/MPA||Chief Executive Officer|
|Adelene Q. Perkins||Chairman of The Board, Chief Executive Officer and President|
Infinity Pharmaceuticals, Inc.
|$536.0K||Compensation as of Fiscal Year 2012.|